Literature DB >> 6577012

Morphological changes in osteosarcoma after chemotherapy--COSS 80.

G Delling, H Krumme, M Salzer-Kuntschik.   

Abstract

Forty-five osteosarcomas were investigated by special methods such as preparation of undecalcified bone tumor tissue, imprint cytology, histochemistry, and quantitative analysis. The morphological regression grades and their relation to chemotherapy are reported by Salzer-Kuntschik et al. (1983). The results presented demonstrate that smaller osteosarcomas respond more favorably than larger tumors. The function of bone-tumor cells, e.g., osteoid production, trabecular tumor bone formation, and mineralization, seems to be more important for the sensitivity to chemotherapy than the cell polymorphism. The estimation of bone-tumor morphology in at least two total areas of the bone tumor is essential in borderline cases (grade III/grade IV). Imprint cytology is very helpful for rapid estimation of the effect of therapy and the demonstration of cellular polymorphism. At the moment, we are not able to determine the effect of chemotherapy from the first biopsy before starting chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6577012     DOI: 10.1007/bf00625049

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  7 in total

1.  [Simplified metacrylate embedding method for undecalcified bone sections].

Authors:  G Delling
Journal:  Beitr Pathol       Date:  1972

2.  [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors].

Authors:  M Salzer-Kuntschik; G Brand; G Delling
Journal:  Pathologe       Date:  1983-05       Impact factor: 1.011

3.  Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.

Authors:  G Rosen; M L Murphy; A G Huvos; M Gutierrez; R C Marcove
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

4.  Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80.

Authors:  M Salzer-Kuntschik; G Delling; G Beron; R Sigmund
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.

Authors:  A G Huvos; G Rosen; R C Marcove
Journal:  Arch Pathol Lab Med       Date:  1977-01       Impact factor: 5.534

6.  Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.

Authors:  G Rosen; B Caparros; A G Huvos; C Kosloff; A Nirenberg; A Cacavio; R C Marcove; J M Lane; B Mehta; C Urban
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

7.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.

Authors:  G Rosen; R C Marcove; B Caparros; A Nirenberg; C Kosloff; A G Huvos
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

  7 in total
  5 in total

1.  Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology.

Authors:  J Knop; G Delling; U Heise; K Winkler
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

2.  Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80.

Authors:  M Salzer-Kuntschik; G Delling; G Beron; R Sigmund
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

3.  Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol.

Authors:  T Bösing; A Roessner; W Hiddemann; W Mellin; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Morphology of pulmonary metastases from osteosarcoma during chemotherapy.

Authors:  T Derstappen; A Roessner; K M Müller; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Nuclear polymorphism in osteosarcomas as a prognostic factor for the effect of chemotherapy. A quantitative study.

Authors:  R Apel; G Delling; H Krumme; K Winkler; M Salzer-Kuntschik
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.